Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP778711.RAd_mES_1OTTXvtFFD73Hg3uR3Ky3trHzezAT0KlETADY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP778711.RAd_mES_1OTTXvtFFD73Hg3uR3Ky3trHzezAT0KlETADY130_assertion type Assertion NP778711.RAd_mES_1OTTXvtFFD73Hg3uR3Ky3trHzezAT0KlETADY130_head.
- NP778711.RAd_mES_1OTTXvtFFD73Hg3uR3Ky3trHzezAT0KlETADY130_assertion description "[None of the low-grade lymphomas showed evidence of Xbp-1 activation; however, Xbp-1 activation was found in 28% of diffuse large B-cell lymphomas, independent of germinal or postgerminal center phenotype, as well as in 48% of plasmablastic lymphomas and 69% of plasma-cell neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP778711.RAd_mES_1OTTXvtFFD73Hg3uR3Ky3trHzezAT0KlETADY130_provenance.
- NP778711.RAd_mES_1OTTXvtFFD73Hg3uR3Ky3trHzezAT0KlETADY130_assertion evidence source_evidence_literature NP778711.RAd_mES_1OTTXvtFFD73Hg3uR3Ky3trHzezAT0KlETADY130_provenance.
- NP778711.RAd_mES_1OTTXvtFFD73Hg3uR3Ky3trHzezAT0KlETADY130_assertion SIO_000772 19389935 NP778711.RAd_mES_1OTTXvtFFD73Hg3uR3Ky3trHzezAT0KlETADY130_provenance.
- NP778711.RAd_mES_1OTTXvtFFD73Hg3uR3Ky3trHzezAT0KlETADY130_assertion wasDerivedFrom befree-20150227 NP778711.RAd_mES_1OTTXvtFFD73Hg3uR3Ky3trHzezAT0KlETADY130_provenance.
- NP778711.RAd_mES_1OTTXvtFFD73Hg3uR3Ky3trHzezAT0KlETADY130_assertion wasGeneratedBy ECO_0000203 NP778711.RAd_mES_1OTTXvtFFD73Hg3uR3Ky3trHzezAT0KlETADY130_provenance.